Use of certain phenylnaphthyl compounds that do not have significant affinity for ERα or ERβ to protect neurons and oligodendrocytes in the treatment of multiple sclerosis (MS)

摘要

The invention provides a new use for certain SERM-like phenylnaphthyl compounds that do not exhibit affinity for alpha or beta type estrogen receptors (ER) in the treatment of multiple sclerosis.